afib_2
TRANSCRIPT
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 1/31
Atrial Fibrillation
Amanda Ryan, D.O.
Cardiology FellowFrankford Hospitals
March 11th, 2008
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 2/31
Atrial Fibrillation Facts Atrial fibrillation is a disorder found in about
2.2 million Americans.
During atrial fibrillation, the atria quiver instead of beating effectively. Blood isn'tpumped completely out of them, so it maypool and clot.
If a piece of a blood clot in the atria leaves theheart and becomes lodged in an artery in thebrain, a stroke results.
About 15 percent of strokes occur in people
with atrial fibrillation.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 3/31
Orderly Function
Orderly function of system is maintained:
by the domination of heart rate by a single pulse generatorknown as pacemaker
by the relatively fast & uniform conduction of electricalsignal via specialized conduction pathways
by relatively long & uniform duration of electrical signalrelative to its velocity of conduction through these pathways
these things assure uniform electrical excitation & contraction of the heart
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 4/31
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 5/31
Define arrhythmia
Any disturbance in the normal sequenceof impulse generation & conduction in
the heart Arrhythmias may occur with or without
underlying heart disease.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 6/31
A normal heart beat
The electrical impulse begins at the sinus (or sinoatrial, SA) node, alsocalled the heart’s natural pacemaker. The SA node is a cluster of specialized cells, located in the right atrium. The SA node produces theelectrical impulses that set the rate and rhythm of your heartbeat. The
impulse spreads through the walls of the right and left atria, causingthem to contract, forcing blood into the ventricles.
The impulse then reaches the atrioventricular (AV) node, which acts asan electrical bridge allowing impulses to travel from the atria to theventricles. There is a short delay before the impulse travels on to the
ventricles. From the AV node, the impulse travels through a pathway of fibers
called the HIS-Purkinje system. This network sends the impulse intothe muscular walls of the ventricles and causes them to contract. Thiscontraction forces blood out of the heart to the lungs and body.
The SA node fires another impulse and the cycle begins again.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 7/31
Mechanisms of Arrhythmia
3 basic causes
suppression or enhancement of initiation or
propagation of action potential ectopic pacemaker activity
reentry of action potential into a pathway
through which its already passedMay be more than one of these things
happening at a time to create a particulararrhythmia
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 8/31
Atrial fibrillation specifically Rapid discharging triggers or foci (rapid
discharge from musculature lining
thoracic veins - esp pulmonary veins)
Autonomic nervous system (maypromote trigger activity & modify the
substrate to facilitate arrhythmia) Substrate abnormalities that permit &
promote wavelet reentry
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 9/31
History
Arrhythmias may or may not causesymptoms, when they do, common
complaints are: palpitations
lightheadedness
syncope shortness of breath
chest pain
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 10/31
More history
Need to establish if there areprecipitating factors such as:
drinking coffee
smoking
exercise
emotional stress
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 11/31
More history
Also need to identify if there aresymptoms of underlying disease that
may be associated with arrhythmias: heart failure
ischemic heart disease
thyroid disease
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 12/31
RISK FACTORS FOR AFIB:
•Increased age
•Coronary heart disease (including myocardial infarction)
•High blood pressure
•Abnormal heart muscle function (including congestive heart failure)
•Disease of the mitral valve•Hyperthyroidism or overdose of thyroid medication
•Pericarditis
•Pulmonary embolism
•Chronic lung diseases (emphysema, asthma, COPD)
•
Alcoholism•Stimulant drug use such as cocaine or decongestants
•Recent heart or lung surgery
•Congenital heart disease
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 13/31
Medications
Thorough questions regarding use of stimulants (including OTC), and Rx
drugs that can contribute toarrhythmias such as: digitalis,theophylline, diuretics, beta blockers or
agonists, TCA’s, antihypertensives, anti-arrhythmic agents.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 14/31
Types of SVT
n Premature atrial contractions (PACs)
n Paroxysmal supraventricular tachycardia
(PSVT)
n Accessory pathway tachycardia (such as
Wolff-Parkinson-White syndrome)
n Atrial tachycardia
n Atrial fibrillation
n Atrial flutter
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 15/31
Atrial Fibrillation
Rapid, uncoordinated generation of electricalimpulses by the atria
Triggered by a PAC that, by reentry, generatesmultifocal impulses at a rate of 300-500/minute
These impulses enter AV node randomly; b/c of slower rate of conduction of AV node & b/c concealedconduction of rapid impulses renders AV node
partially refractory.
Ventricular rate slower than atrial and is irregular
Untreated pts, usually 150-200 ventricular rate
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 16/31
Atrial Fibrillation
May occur paroxysmally, often in young ptsassociated with caffeine, alcohol intoxication, PSVT’s,sinus tachycardia, stress, nicotine.
Most common arrhythmia encountered in practice,frequency increases with age.
10% of those over 65
Major noncardiac disease associated ishyperthyroidism.
Predisposing heart conditions
hypertension
atherosclerosis
rheumatic heart disease (esp. mitral valve involvement)
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 17/31
RISK FACTORS FOR AFIB:
•Increased age
•Coronary heart disease (including myocardial infarction)
•High blood pressure
•Congestive heart failure
•Obstructive sleep aprea•Disease of the mitral valve
•Hyperthyroidism or overdose of thyroid medication
•Pericarditis
•Pulmonary embolism
•
Chronic lung diseases (emphysema, asthma, COPD)•Alcoholism
•Stimulant drug use such as cocaine or decongestants
•Recent heart or lung surgery
•Congenital heart disease
•WPW syndrome
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 18/31
Reversible Risk Factors MI
Recent cardiac surgery
Thyroid dysfunction
Acute pulmonary disease
Pericarditis Myocarditis
Acute alcohol ingestion
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 19/31
Atrial Fibrillation
Palpitations & fatigue are most common symptoms
If ventricular response is fast, pts often complain of feeling “strange”, weak, or faint.
Those with heart failure, ischemic CM, or valvularheart disease are often symptomatic b/c of the lossof atrial “kick” to cardiac output, especially noted onexertion.
Irregularly irregular heartbeat and pulse withvariation of sounds on auscultation.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 20/31
Atrial Fibrillation
ECG shows rapid irregular fibrillatory atrialactivity with rates 300-500; no p waves are
present Ventricular rhythm is irregularly irregular
QRS usually normal
Most serious potential consequence iscardioembolic stroke
Asymptomatic pts at greatest risk fortachycardia-induced cardiomyopathy
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 21/31
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 22/31
Distinguishing Afib on ECG A flutter has repetitive, stereotypical
undulations in baseline, resulting in
sawtooth pattern. MAT shows PAC’s with at least 3
different morphological types of P
waves that are distinguished from atrialfibrillation by presence of isoelectricbaseline between complexes.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 23/31
Wide QRS complex afib Presence of preexisting BBB
Aberrant conduction of a
supraventricular impulse (Ashmanphenomenon) - after a long RR intrevalan early atrial impulse is conducted
aberrantly b/c one BB is not fullyrecovered or is still partially refractory
Ventricular ectopy
Preexcitation
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 24/31
Management
Hemodynamically stable pts in hospitalized setting,rate control is usually initial goal.
Hospitalized pts
diltiazem
digoxin
beta blockers
Amiodarone also good option - especially for thosewith borderline BP’s.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 25/31
More Management
Shock or severe hypotension - electrical cardioversionis treatment of choice, it is synchronized (on the R wave).
Usually start with 100-200J, can go to 360 if this isnot successful
Risk for thromboembolism exists, in controlledenvironment, can do TEE to look for clot (esp. in LA
appendage), but if unstable, benefits outweigh risks.
If this fails, may load with IV ibutilide or IV
procainamide, then retry.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 26/31
Subsequent management
Anticoagulation is indicated even in paroxysmal in pts who haveat least 1 risk factor for stroke - CHADS criteria (CHF &/or CAD,HTN, Advanced Age, DM, prior stroke). Goal INR 2-3.
In those with “lone” afib, Aspirin alone is accetable for anticoag. Can undergo electrical or chemical cardioversion - medication
options ibutilide, amiodarone, propafenone (normal heart),sotalol, flecainide.
AFFIRM & RACE trials indicated rate control with long-term
anticoagulation was associated with same outcomes as rhythmcontrol strategies.
Rate control options include digoxin, B-blocker, CCB
Most cardiologists believe, an initial attempt at cardioversionafter an appropriate period of anticoagulation should be tried at
least once.
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 27/31
Facts about afib
only 25% of pts will remain in sinusrhythm on their own
up to 50% maintain sinus rhythm withlong-term antiarrhymic agents
The treatment decisions require risk-
benefit analysis. Refractory symptomatic afib -
radiofrequency AV node ablation &
permanent pacemaker
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 28/31
AFFIRM >4000 pts >65 years of age
hx of afib + additional risk factors randomly assignedto rate vs rhythm control
mean follow up 3.5 yrs
Essentially no statistically significant difference inmortality, stroke, quality of life or development of HF
Rhythm control trend towards higher mortality & hospitalizations
Sinus rhythm was associated with improved survival,offset by decreased survival associated withantiarrhythmics
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 29/31
CHADS-2 Congestive heart failure
hypertension
advanced age (>75)
diabetes mellitus
stroke or TIA (2 points) Annual stroke rate is 1.2% with CHADS
score 0; risk increases to 44% with 6
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 30/31
7/29/2019 AFib_2
http://slidepdf.com/reader/full/afib2 31/31